RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Nina Harawa to Costs and Cost Analysis

Back to Details
This is a "connection" page, showing publications Nina Harawa has written about Costs and Cost Analysis.
Nina Harawa
Connection Strength
0.056
Costs and Cost Analysis
  1. Arbanas JC, Damberg CL, Leng M, Harawa N, Sarkisian CA, Landon BE, Mafi JN. Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program. JAMA Intern Med. 2023 08 01; 183(8):885-889.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support